Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Blue light and platinum fight cancer

BioPhotonics
Feb 2011
COVENTRY, UK – Blue light could become a big cancer killer by activating what could be a powerful platinum-based treatment.

A research team led by the University of Warwick, with researchers at Ninewells Hospital Dundee and the University of Edinburgh, has discovered a new platinum-based light-activated compound that is up to 80 times more powerful than other platinum-based anti-cancer drugs. In addition, this compound is stable and much more targeted than similar treatments, and it is water-soluble, so the body can simply dissolve and flush it after use.

The team had previously found a UV-activated platinum-based compound, but the narrowness of the UV wavelength would have limited its use. But the new compound, known as trans,trans,trans-[Pt(N3)2(OH)2(py)2], can be activated by visible blue or even green light.

It was tested at the hospital on cultivated esophageal cancer cells. Once stimulated by blue light, the compound was highly effective, killing 50 percent of the cancer cells with a concentration of just 8.4 μmol per liter. The researchers are also beginning to examine the compound’s effectiveness against ovarian and liver cancer cells.

The results of the current study were published in Angewandte Chemie International Edition, Vol. 49, Issue 47, pp. 8905-8908, Nov. 15, 2010.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!